These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

638 related items for PubMed ID: 23236027

  • 1. Incidence, predictors and impact of bleeding after transcatheter aortic valve implantation using the balloon-expandable Edwards prosthesis.
    Borz B, Durand E, Godin M, Tron C, Canville A, Litzler PY, Bessou JP, Cribier A, Eltchaninoff H.
    Heart; 2013 Jun; 99(12):860-5. PubMed ID: 23236027
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Procedural results and 30-day clinical events analysis following Edwards transcatheter aortic valve implantation in 48 consecutive patients: initial experience.
    Zhao QM, Lognone T, Ivascau C, Sabatier R, Roule V, Dahdouh Z, Massetti M, Grollier G.
    Chin Med J (Engl); 2012 Aug; 125(16):2807-10. PubMed ID: 22932071
    [Abstract] [Full Text] [Related]

  • 4. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).
    Généreux P, Cohen DJ, Williams MR, Mack M, Kodali SK, Svensson LG, Kirtane AJ, Xu K, McAndrew TC, Makkar R, Smith CR, Leon MB.
    J Am Coll Cardiol; 2014 Mar 25; 63(11):1100-9. PubMed ID: 24291283
    [Abstract] [Full Text] [Related]

  • 5. Prospective analysis of 30-day safety and performance of transfemoral transcatheter aortic valve implantation with Edwards SAPIEN XT versus SAPIEN prostheses.
    Eltchaninoff H, Durand E, Borz B, Godin M, Tron C, Litzler PY, Bessou JP, Bejar K, Fraccaro C, Sanchez-Giron C, Dacher JN, Bauer F, Cribier A.
    Arch Cardiovasc Dis; 2012 Mar 25; 105(3):132-40. PubMed ID: 22520795
    [Abstract] [Full Text] [Related]

  • 6. Transcatheter aortic valve implantation with the Edwards SAPIEN versus the Medtronic CoreValve Revalving system devices: a multicenter collaborative study: the PRAGMATIC Plus Initiative (Pooled-RotterdAm-Milano-Toulouse In Collaboration).
    Chieffo A, Buchanan GL, Van Mieghem NM, Tchetche D, Dumonteil N, Latib A, van der Boon RM, Vahdat O, Marcheix B, Farah B, Serruys PW, Fajadet J, Carrié D, de Jaegere PP, Colombo A.
    J Am Coll Cardiol; 2013 Feb 26; 61(8):830-6. PubMed ID: 23333140
    [Abstract] [Full Text] [Related]

  • 7. A meta-analysis of mortality and major adverse cardiovascular and cerebrovascular events in patients undergoing transfemoral versus transapical transcatheter aortic valve implantation using edwards valve for severe aortic stenosis.
    Panchal HB, Ladia V, Amin P, Patel P, Veeranki SP, Albalbissi K, Paul T.
    Am J Cardiol; 2014 Dec 15; 114(12):1882-90. PubMed ID: 25438917
    [Abstract] [Full Text] [Related]

  • 8. Effect of transcatheter (via femoral artery) aortic valve implantation on the platelet count and its consequences.
    Gallet R, Seemann A, Yamamoto M, Hayat D, Mouillet G, Monin JL, Gueret P, Couetil JP, Dubois-Randé JL, Teiger E, Lim P.
    Am J Cardiol; 2013 Jun 01; 111(11):1619-24. PubMed ID: 23523059
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry.
    Schymik G, Lefèvre T, Bartorelli AL, Rubino P, Treede H, Walther T, Baumgartner H, Windecker S, Wendler O, Urban P, Mandinov L, Thomas M, Vahanian A.
    JACC Cardiovasc Interv; 2015 Apr 27; 8(5):657-69. PubMed ID: 25946437
    [Abstract] [Full Text] [Related]

  • 11. Safety and effectiveness of a selective strategy for coronary artery revascularization before transcatheter aortic valve implantation.
    Gasparetto V, Fraccaro C, Tarantini G, Buja P, D'Onofrio A, Yzeiraj E, Pittarello D, Isabella G, Gerosa G, Iliceto S, Napodano M.
    Catheter Cardiovasc Interv; 2013 Feb 27; 81(2):376-83. PubMed ID: 22461314
    [Abstract] [Full Text] [Related]

  • 12. Midterm outcomes after transcatheter aortic valve implantation.
    Lotfi S, Dohmen G, Götzenich A, Haushofer M, Spillner JW, Autschbach R, Hoffmann R.
    Innovations (Phila); 2014 Feb 27; 9(5):343-7; discussion 348. PubMed ID: 25238419
    [Abstract] [Full Text] [Related]

  • 13. Predictors and outcomes after transcatheter aortic valve implantation using different approaches according to the valve academic research consortium definitions.
    Seiffert M, Schnabel R, Conradi L, Diemert P, Schirmer J, Koschyk D, Linder M, Kersten JF, Grosser A, Wilde S, Blankenberg S, Reichenspurner H, Baldus S, Treede H.
    Catheter Cardiovasc Interv; 2013 Oct 01; 82(4):640-52. PubMed ID: 23172652
    [Abstract] [Full Text] [Related]

  • 14. Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries.
    Ihlberg L, Nissen H, Nielsen NE, Rück A, Busund R, Klaarborg KE, Soendergaard L, Harnek J, Miettinen H, Eskola M, Wahba A, Laine M.
    J Thorac Cardiovasc Surg; 2013 Nov 01; 146(5):1047-54; discussion 1054. PubMed ID: 23998786
    [Abstract] [Full Text] [Related]

  • 15. Occurrence and prognostic impact of systemic inflammatory response syndrome in transfemoral and transapical aortic valve implantation with balloon- and self-expandable valves.
    Schwietz T, Behjati S, Gafoor S, Seeger F, Doss M, Sievert H, Zeiher AM, Fichtlscherer S, Lehmann R.
    EuroIntervention; 2015 Apr 01; 10(12):1468-73. PubMed ID: 24970670
    [Abstract] [Full Text] [Related]

  • 16. Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience.
    Godino C, Maisano F, Montorfano M, Latib A, Chieffo A, Michev I, Al-Lamee R, Bande M, Mussardo M, Arioli F, Ielasi A, Cioni M, Taramasso M, Arendar I, Grimaldi A, Spagnolo P, Zangrillo A, La Canna G, Alfieri O, Colombo A.
    JACC Cardiovasc Interv; 2010 Nov 01; 3(11):1110-21. PubMed ID: 21087745
    [Abstract] [Full Text] [Related]

  • 17. Transapical aortic valve implantation in patients with previous cardiac surgery.
    Papadopoulos N, Ilioska P, Fichtlscherer S, Lehmann R, Beiras Fernandez A, Moritz A, Doss M, Zierer A.
    Ann Thorac Surg; 2014 Jan 01; 97(1):37-42. PubMed ID: 24075497
    [Abstract] [Full Text] [Related]

  • 18. Emergency cardiac surgery during transfemoral and transapical transcatheter aortic valve implantation: incidence, reasons, management, and outcome of 411 patients from a single center.
    Griese DP, Reents W, Kerber S, Diegeler A, Babin-Ebell J.
    Catheter Cardiovasc Interv; 2013 Nov 01; 82(5):E726-33. PubMed ID: 23765631
    [Abstract] [Full Text] [Related]

  • 19. Cerebral embolization during transcatheter aortic valve implantation: a transcranial Doppler study.
    Kahlert P, Al-Rashid F, Döttger P, Mori K, Plicht B, Wendt D, Bergmann L, Kottenberg E, Schlamann M, Mummel P, Holle D, Thielmann M, Jakob HG, Konorza T, Heusch G, Erbel R, Eggebrecht H.
    Circulation; 2012 Sep 04; 126(10):1245-55. PubMed ID: 22899774
    [Abstract] [Full Text] [Related]

  • 20. Incidence and prognosis of vascular complications after transcatheter aortic valve implantation.
    Mwipatayi BP, Picardo A, Masilonyane-Jones TV, Larbalestier R, Thomas S, Turner J, Vijayan V, Yong G.
    J Vasc Surg; 2013 Oct 04; 58(4):1028-36.e1. PubMed ID: 23993436
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.